title: Prevention of methylmercury-induced mitochondrial depolarization, glutathione depletion and cell death by 15-deoxy-delta-12,14-prostaglandin J(2).
abstract: Methylmercury (MeHg) is an environmental toxin that causes severe neurological complications in humans and experimental animals. In addition to neurons, glia in the central nervous system are very susceptible to MeHg toxicity. Pretreatment of glia with the prostaglandin derivative, 15-deoxy-delta-12,14-prostaglandin J(2) (15d-PGJ(2)), caused a significant protection against MeHg cytotoxicity. Results with the C6 glioma cells demonstrated that the protection was dependent on the duration of pretreatment, suggesting that time was required for the up-regulation of cellular defenses. Subsequent experiments indicated that 15d-PGJ(2) prevented MeHg induced mitochondrial depolarization. Similar protection against MeHg cytotoxicity was observed in primary cultures of mouse glia. Analysis of cellular glutathione (GSH) levels indicated that 15d-PGJ(2) caused an up-regulation of GSH and prevented MeHg-induced GSH depletion. Buthionine sulfoximine (BSO), a GSH synthesis inhibitor, completely inhibited the GSH induction by 15d-PGJ(2). However, BSO did not prevent the stabilization of mitochondrial potential and only partially prevented the protection caused by 15d-PGJ(2). While induction of heme oxygenase-1 was implicated in the cytoprotection by 15d-PGJ(2) under some experimental conditions, additional experiments indicated that this enzyme was not involved in the cytoprotection observed in this system. Together, these results suggested that while up-regulation of GSH by 15d-PGJ(2) might help cells to defend against MeHg toxicity, there may be other yet unidentified mechanism(s) initiated by 15d-PGJ(2) treatment that contributed to its protection against MeHg cytotoxicity.
authors.affiliation: Department of Neurobiology & Developmental Sciences, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. changjasony@uams.edu
authors.forename: Jason Y
authors.initials: JY
authors.lastname: Chang
authors.forename: Pao-Feng
authors.initials: PF
authors.lastname: Tsai
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001562:Benzimidazoles / Q000494:pharmacology*; D019328:Buthionine Sulfoximine / Q000494:pharmacology; D002232:Carbocyanines / Q000494:pharmacology*; D016923:Cell Death / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism*; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects*; D008767:Methylmercury Compounds / Q000633:toxicity*; D051379:Mice; D008810:Mice, Inbred C57BL; D008928:Mitochondria / Q000187:drug effects*; D009457:Neuroglia / Q000187:drug effects; D013997:Time Factors; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D001562:Benzimidazoles; D002232:Carbocyanines; D004791:Enzyme Inhibitors; D005904:Glial Fibrillary Acidic Protein; D008767:Methylmercury Compounds; C068624:5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine; D019328:Buthionine Sulfoximine; D005978:Glutathione
references.citation: Brain Res. 2001 Jul 27;908(2):149-54
references.pmid: 11454325
references.citation: Am J Physiol Heart Circ Physiol. 2006 May;290(5):H1777-87
references.pmid: 16387790
references.citation: N Engl J Med. 2003 Oct 30;349(18):1731-7
references.pmid: 14585942
references.citation: Immunopharmacol Immunotoxicol. 1993 Mar-Jun;15(2-3):273-90
references.pmid: 8349953
references.citation: J Neuroimmunol. 2006 Feb;171(1-2):17-28
references.pmid: 16225932
references.citation: Biochem Pharmacol. 2003 Oct 15;66(8):1381-91
references.pmid: 14555212
references.citation: Neurotoxicology. 1996 Spring;17(1):93-106
references.pmid: 8784821
references.citation: J Cell Physiol. 2006 Mar;206(3):655-63
references.pmid: 16222706
references.citation: J Neurochem. 2007 Sep;102(5):1625-1634
references.pmid: 17697048
references.citation: Toxicology. 2004 Nov 15;204(2-3):175-85
references.pmid: 15388243
references.citation: J Neurosci Res. 2002 Dec 1;70(5):703-11
references.pmid: 12424738
references.citation: J Neurosci Res. 2003 Jun 15;72(6):747-55
references.pmid: 12774315
references.citation: Annu Rev Pharmacol Toxicol. 2007;47:89-116
references.pmid: 16968214
references.citation: J Neurosci Res. 2007 Aug 1;85(10):2186-95
references.pmid: 17526019
references.citation: Mol Pharmacol. 2008 Feb;73(2):274-81
references.pmid: 18000030
references.citation: Toxicol Appl Pharmacol. 2002 Jan 1;178(1):52-61
references.pmid: 11781080
references.citation: Neurotoxicology. 2004 Sep;25(5):741-60
references.pmid: 15288506
references.citation: J Biol Chem. 2000 Apr 14;275(15):11291-9
references.pmid: 10753940
references.citation: Toxicol Appl Pharmacol. 1999 May 15;157(1):23-35
references.pmid: 10329504
references.citation: BMC Pharmacol. 2004 May 18;4:6
references.pmid: 15149553
references.citation: J Biol Chem. 2004 May 21;279(21):21929-37
references.pmid: 15024026
references.citation: BMC Pharmacol. 2001;1:10
references.pmid: 11737865
references.citation: Neurotoxicology. 2007 Jul;28(4):720-6
references.pmid: 17442395
references.citation: J Immunol. 2005 Nov 1;175(9):5744-50
references.pmid: 16237065
references.citation: Antioxid Redox Signal. 2002 Apr;4(2):249-57
references.pmid: 12006176
references.citation: J Biol Chem. 2006 Jul 28;281(30):21377-21386
references.pmid: 16737963
references.citation: J Neurosci Res. 1999 Jun 15;56(6):652-8
references.pmid: 10374820
references.citation: Antioxid Redox Signal. 2007 May;9(5):543-52
references.pmid: 17330989
references.citation: Nat Med. 1999 Jun;5(6):698-701
references.pmid: 10371510
references.citation: J Biol Chem. 2004 Oct 29;279(44):46263-70
references.pmid: 15319433
references.citation: BMC Ophthalmol. 2003 Mar 21;3:5
references.pmid: 12659653
references.citation: Eur J Neurosci. 2000 Jul;12(7):2215-23
references.pmid: 10947800
references.citation: Toxicology. 2005 Sep 15;213(1-2):97-106
references.pmid: 15982794
references.citation: J Neurochem. 1998 Dec;71(6):2497-504
references.pmid: 9832148
references.citation: Eur J Neurosci. 2003 Jun;17(11):2249-55
references.pmid: 12814358
references.citation: Invest Ophthalmol Vis Sci. 2003 Jul;44(7):2999-3004
references.pmid: 12824244
references.citation: Brain Res. 2000 Jun 9;867(1-2):115-21
references.pmid: 10837804
references.citation: J Neurochem. 2002 Jun;81(5):1052-60
references.pmid: 12065618
references.citation: Neuroreport. 2000 Apr 27;11(6):1185-9
references.pmid: 10817588
references.citation: J Pharmacol Exp Ther. 2003 Mar;304(3):949-58
references.pmid: 12604669
references.citation: Neurotoxicology. 1999 Oct;20(5):793-804
references.pmid: 10591515
references.citation: Nature. 1998 Jan 1;391(6662):79-82
references.pmid: 9422508
references.citation: Annu Rev Pharmacol Toxicol. 1999;39:151-73
references.pmid: 10331080
references.citation: Mol Cell Biol. 2004 Jan;24(1):36-45
references.pmid: 14673141
references.citation: Invest Ophthalmol Vis Sci. 2006 Nov;47(11):5098-105
references.pmid: 17065531
references.citation: J Immunol. 2002 Apr 1;168(7):3563-9
references.pmid: 11907120
references.citation: Mol Cell Biol. 2000 Mar;20(5):1692-8
references.pmid: 10669746
references.citation: Nature. 1998 Jan 1;391(6662):82-6
references.pmid: 9422509
references.citation: Neurotoxicology. 2000 Dec;21(6):1135-44
references.pmid: 11233760
references.citation: Med Res Rev. 2001 May;21(3):185-210
references.pmid: 11301410
references.citation: Neurochem Res. 2001 Nov;26(11):1187-93
references.pmid: 11874199
references.citation: Toxicol Appl Pharmacol. 1997 Dec;147(2):319-30
references.pmid: 9439727
references.citation: Toxicology. 1997 Dec 31;124(3):211-24
references.pmid: 9482123
references.citation: Cytometry A. 2003 Jan;51(1):16-25
references.pmid: 12500301
references.citation: Physiol Rev. 2006 Apr;86(2):583-650
references.pmid: 16601269
references.citation: Neurotoxicology. 1996 Spring;17(1):17-26
references.pmid: 8784815
references.citation: Neurotoxicology. 2006 Jul;27(4):492-500
references.pmid: 16513172
references.citation: Arterioscler Thromb Vasc Biol. 2001 Nov;21(11):1846-51
references.pmid: 11701476
references.citation: Environ Res. 1998 May;77(2):149-59
references.pmid: 9600808
references.citation: Trends Immunol. 2003 Aug;24(8):449-55
references.pmid: 12909459
references.citation: Toxicol Appl Pharmacol. 2006 Oct 15;216(2):206-15
references.pmid: 16854443
references.citation: Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4668-73
references.pmid: 10200320